Search results
If You Invested $1000 in AbbVie a Decade Ago, This is How Much It'd Be Worth Now
Zacks via Yahoo News· 1 month agoFor most investors, how much a stock's price changes over time is important. This factor can impact...
Here's Why AbbVie (ABBV) is a Strong Momentum Stock
Zacks via Yahoo News· 1 month agoWhether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks...
Why AbbVie (ABBV) is a Top Value Stock for the Long-Term
Zacks via Yahoo News· 2 months agoWhether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the...
Health officials warn Californians of risks of fake Botox. Here's what to look for
LA Times via Yahoo News· 3 months agoFake versions of Botox have popped up in California, raising alarm among officials who warn that counterfeit product can lead to slurred speech and breathing issues.
AbbVie (ABBV) Announces Appointment of New CEO Robert Michael
Zacks via Yahoo News· 5 months agoAbbVie ABBV announced that its current president and chief operating officer, Robert A. Michael, has...
Here's How Much a $1000 Investment in AbbVie Made 10 Years Ago Would Be Worth Today
Zacks via Yahoo News· 7 months agoHow much a stock's price changes over time is important for most investors, since price performance...
The Zacks Analyst Blog Highlights AbbVie, Exxon Mobil, Kontoor Brands, Select Water Solutions and...
Zacks via Yahoo News· 9 months agoFor Immediate Release Chicago, IL – November 1, 2023 – Zacks.com announces the list of stocks...
Can AbbVie (ABBV) Protect Revenues After Humira Patent Loss?
Zacks via Yahoo News· 11 months agoAbbVie’s ABBV key blockbuster immunology medicine, Humira lost patent protection in the United...
Zacks.com featured highlights include Dillard's, Suzano, Atkore, Nexstar Media Group and AbbVie
Zacks via Yahoo News· 1 year agoFor Immediate Release Chicago, IL – July 10, 2023 – Stocks in this week’s article are Dillard's,...
Pharma Stock Roundup: FDA Okays PFE RSV Jab for Elderly, AZN Ends Brazikumab Studies
Zacks via Yahoo News· 1 year agoFDA approves Pfizer's (PFE) RSV vaccine for older adults and AstraZeneca (AZN) and Merck's (MRK)...